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Abstract
Purpose To investigate whether the relationships between
established risk factors and breast cancer risk differ between
three ethnic groups in New Zealand, namely Ma¯ori, Pacific,
and non-Ma¯ori/non-Pacific women.
Methods The study is a multi-ethnic, age-, and ethnicity-
matched population-based case–control study of breast
cancer in women. Women with a primary, invasive breast
cancer registered on the New Zealand Cancer Registry
between 1 April 2005 and 30 April 2006, and Ma¯ori or
Pacific women diagnosed to 30 April 2007 were eligible.
Control women were identified from the New Zealand
Electoral Roll, stratified by ethnicity, then frequency mat-
ched on age to the cases. Logistic regression was used to
estimate odds ratios (OR) and 95 % confidence intervals
(CI) between exposures and breast cancer risk in three
ethnic groups separately. Likelihood ratio tests were used
to test for modification of the effects by ethnicity. Post-
stratification weighting of the controls was used to account
for differential non-response by deprivation category.
Results The study comprised 1,799 cases (302 Ma¯ori, 70
Pacific, 1,427 non-Ma¯ori/non-Pacific) and 2,543 controls
(746 Ma¯ori, 194 Pacific, 1,603 non-Ma¯ori/non-Pacific),
based on self-identified ethnicity. Ma¯ori women were more
likely to have ER and PR positive breast cancer compared
to other ethnicities. There were marked differences in
exposure prevalence between ethnicities and some differ-
ing patterns of risk factors for breast cancer between the
three main ethnic groups. Of interest was the strong rela-
tionship between number of children and lower breast
cancer risk in Pacific women (OR for 4 or more vs. 1 child
OR 0.13, 95 % CI 0.05–0.35) and a higher risk of breast
cancer associated with smoking (OR 1.76, 95 % CI
1.25–2.48) and binge drinking (5 or more vs. 1–2 drinks
per occasion, OR 1.55, 95 % CI 1.07–2.26) in Ma¯ori
women. Some of the documented results were attenuated
following post-stratification weighting.
Conclusions The findings of this study need to be inter-
preted with caution, given the possibility of selection bias
due to low response rates among some groups of women.
Reducing the burden of breast cancer in New Zealand is
likely to require different approaches for different ethnic
groups.
Keywords Breast cancer  Multi-ethnic 
Case–control study  New Zealand
Introduction
The burden of breast cancer in both developed and devel-
oping countries is high and continues to rise. A large body
of evidence of risk factors for breast cancer exists
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internationally. The most clearly established risk factors
are reproductive variables [1], for example early menarche,
late age at first birth, low parity, and late menopause, which
are not amenable to intervention. Lifestyle factors which
have been related to breast cancer in observational studies
include alcohol consumption, low levels of physical
activity, and smoking [2–4]. The multi-ethnic nature of the
New Zealand population, with different ethnic groups
exhibiting differences in breast cancer risk and different
risk factor profiles, provides an opportunity for further
exploration of some of these issues.
Ma¯ori are the indigenous people of New Zealand,
comprising about 15 % of the population. Pacific people,
who have migrated from small Pacific islands (e.g., Samoa,
Cook Islands, Tonga, and Niue), comprise a further 7 %.
Migration began as early as the late 1800s, but the majority
of migration of Pacific people to New Zealand occurred in
the 1960s and 1970s. The remainder of the population is
composed primarily of people, originating from the United
Kingdom and Europe (77 %), with a further 10 % of
peoples from Asian countries (South East Asian, Chinese,
Indian, and Other Asian). These last two groups are here-
after referred to as non-Ma¯ori/non-Pacific. The figures
quoted here add up to over 100 %, since people who
identify with more than one ethnicity are included in each
ethnic population with which they identify [5].
Evidence regarding ethnic differences in breast cancer
rates in New Zealand is mixed, because of changes in how
ethnicity is measured, as well as changes in incidence over
time. Older data for Ma¯ori suggest that their higher risk is
restricted to those who identify as solely Ma¯ori, but is not
apparent in the total Ma¯ori population [6]. More recent data
are indicative of a higher risk compared to European/Other
New Zealanders in the total Ma¯ori population, based on
self-identified ethnicity [7], as well as an ‘‘ever-Ma¯ori’’
indicator [8], based on ethnicity as reported in electronic
health records. The incidence of breast cancer in Ma¯ori
women appears to be increasing faster than that in other
ethnicities, with age-standardized rate differences between
Ma¯ori and European/Other women having increased from 8
per 100,000 in 1981–1986 to 39 per 100,000 in 2001–2004
[7]. Overall, Pacific women living in New Zealand do not
appear to have a higher risk than non-Ma¯ori/non-Pacific
women [9, 10], although recent data suggest that young
Pacific women (under 45 years) have a higher risk of breast
cancer than European/Other New Zealanders, whereas
older Pacific women (over 65 years) have a lower risk [7].
These differing patterns of breast cancer risk are not easily
explained by known risk factor distributions [7].
Epidemiological studies of causal effects are limited by
issues of confounding. Since most studies of breast cancer
risk factors have been undertaken in countries where con-
founding structures are similar, it is not possible to know
whether repeatedly observed associations are causal, or
whether they are due to confounding. Alternative methods
to address these issues have been proposed, including
comparison of results from populations where confounding
structures may differ [11]. New Zealand is a multicultural
society, and confounding structures between important
breast cancer risk factors may differ between ethnic groups,
as well as differing from those in other developed coun-
tries. We have therefore used this opportunity to explore
whether lifestyle factors affect breast cancer risk differen-
tially between different ethnic groups.
The overall aim of the study was to explore the rela-
tionship between health behaviors across the lifecourse and
breast cancer risk in three ethnic groups (Ma¯ori, Pacific and
non-Ma¯ori/non-Pacific). This initial paper describes the
methods used, response rates obtained, and demographics
of the participants in the study and explores whether the
relationships between established risk factors and breast
cancer differ between three ethnic groups in New Zealand.
Methods
The study is a multi-ethnic, age-, and ethnicity-matched
population-based case–control study of breast cancer in
women, with over-sampling of Ma¯ori and Pacific women,
to ensure sufficient statistical power for most ethnic-spe-
cific analyses.
Pilot study
To address issues of likely response rates and acceptability
of the questionnaire content, a pilot study of 15 cases and 15
controls was conducted between November 2003 and
February 2004. Cases were identified from the New Zealand
Cancer Registry (NZCR); controls were selected from
women on the New Zealand Electoral Roll, as described in
detail under the main study, below. The pilot study identi-
fied that this method was inappropriate for Pacific women,
most probably due to their higher levels of mobility and
English as a second language. We therefore expanded our
methods for recruitment of Pacific women controls in the
main study. No issues of unacceptability or other method-
ological problems were identified during the pilot study.
Main study
All women with a primary, invasive breast cancer (ICD10
C50.0-C50.9), registered on the NZCR between 1 April
2005 and 30 April 2006, were eligible for inclusion. In
addition, to ensure sufficient numbers of Ma¯ori and Pacific
women, cases who were identified on the Registry as being
of Ma¯ori or Pacific ethnicity, diagnosed between 1 April
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2006 and 30 April 2007 were eligible. Using data on the
NZCR, the facility where the woman had been diagnosed
was identified, and the Clinical Records Department (CRD)
of that hospital was contacted, to ask for details of the
woman’s GP. GPs were contacted, to ask if they knew of
any reason why the woman should not be contacted, and if
not, to supply contact details for the woman. Two attempts
were made to contact each GP. Following this, each
woman was contacted by post, followed by a reminder
letter if no reply was received. The cases completed their
questionnaires between January 2006 and December 2008.
Control women were stratified by ethnicity, then fre-
quency matched on age, based on the expected age distri-
bution in the cases from previously published incidence
data, using 5-year age bands. The main method to identify
population-based controls was through the electoral roll,
registration for which is mandatory in New Zealand. There
are two electoral rolls, ‘‘General’’ and ‘‘Ma¯ori.’’ Ma¯ori
people can choose the electoral roll on which they want to
be included. All people on the General Electoral Roll are
asked to self-identify whether or not they are Ma¯ori or the
descendent of a Ma¯ori.
Throughout the control selection process, which took
place between November 2005 and October 2009, the most
recent of the 2005, 2006, or 2008 Electoral Rolls was used.
Ma¯ori women were randomly chosen in equal numbers
from the General and Ma¯ori Electoral Roll, using the ‘‘Of
Ma¯ori descent’’ indicator on the General Electoral Roll to
identify Ma¯ori. For Pacific women, it was originally
planned to use the General Electoral Roll to identify pop-
ulation-based controls. The first, middle, and last names of
all women were searched on the General Electoral Roll, to
identify whether these women were likely to be of Pacific
ethnicity. Given that the majority of Pacific women in the
target age group would be first generation migrants, we
expected that the validity of this method would be rela-
tively high. However, the response rate to this method was
low (see below). Therefore, this was supplemented through
two methods: (1) GPs of Pacific cases were invited to
identify one of their patients, matched by age to the case at
their practice, who: self-identified as being of Pacific eth-
nicity; had never had a diagnosis of breast cancer, and were
not too ill to participate (2) controls were selected by
trained Pacific nurses working at the Pacific Community
Health Services from the main District Health Board
(DHB) areas, namely Auckland, Wellington, and Canter-
bury. The nurses identified eligible controls on their current
case list using the same criterion listed above for GPs and
invited them to participate. For non-Ma¯ori/non-Pacific
women, controls were identified from the General Electoral
Roll among those eligible to act as controls, that is, based
on the age distribution of cases, without the ‘‘Of Ma¯ori
descent’’ indicator, and without a Pacific-sounding name.
Exposure measurement
All women were given the option of completing the
questionnaire at home and returning it by post, or by
completing it over the telephone. In the latter case, the
participant had a copy of the questionnaire in front of her,
while she answered the questions which were asked by the
trained interviewer. Ma¯ori and Pacific women were also
given the option of face-to-face interviews. All study
materials were translated into Samoan and Tongan (the
most commonly spoken Pacific languages in New Zealand)
and provided to the participants on request. Face-to-face
and telephone interviews were conducted in the language
of choice of the interviewee.
The questionnaire comprised sections on socio-demo-
graphics, childhood exposures, lifecourse exposures to
health behaviors, and comprehensive occupational and
reproductive histories. For current exposures, both cases
and controls were asked to report their lifestyles 1 year
previously. Control women were asked about attendance at
screening, and cases were asked about their route to
diagnosis and experiences associated with that process.
Where possible, validated questions were used [12–14],
and for some exposures, questions were based on previ-
ously used questionnaires. Women were asked to report
their weight and height, from which body mass index
(BMI) was determined. A disposable tape measure was
sent with the questionnaire booklet, and participants were
given instructions about how to measure their waist and hip
circumferences, from which waist–hip ratio (WHR) was
determined. Waist–height ratio (WHtR) was similarly
calculated from reported measures. A copy of the ques-
tionnaire is available from the authors on request.
Age was defined as age at diagnosis for the cases and
age at interview for the controls. Due to an error in the
questionnaire, age at menopause could not be determined
for the majority of women. The following rules were used
to determine pre-/postmenopausal status at the time of
diagnosis for the cases and at the time of questionnaire
completion for the controls. Women were classified as
premenopausal if they had a menstrual period in the last
3 months, or if their periods had stopped due to pregnancy/
lactation, or use of hormonal birth control. Women were
classified as postmenopausal if they reported natural
menopause, surgical menopause involving bilateral ooph-
orectomy, or use of hormone replacement therapy (HRT).
Women who did not fall into these categories, who
reported surgical menopause without bilateral oophorec-
tomy, and other or unknown reasons for menses cessation
were classified in an ‘‘other amenorrhea’’ category. This
category was then dichotomized for analysis; women less
than 49 years were considered premenopausal (n = 118)
and women of 49 years and older were considered
Cancer Causes Control (2013) 24:135–152 137
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postmenopausal (n = 490). The cut off of 49 years was
used as this is the median age at menopause reported in
recent UK and New Zealand data [15, 16].
Deprivation was assessed using the NZDep2006 mea-
sure [17], an area-based measure derived from the 2006
census variables, based on place of residence at the time of
diagnosis of the case and the time of interview of the
control. Educational achievement was grouped into whe-
ther a woman had a postschool qualification, a school
qualification only, or no qualifications. Therefore, women
who had left school with no qualifications but subsequently
obtained a postschool qualification were categorized in the
most educated group. Exercise was assessed using the
Godin questionnaire [12], based on self-reported exercise
frequency and intensity, which were combined according
to the recommended algorithm and analyzed in quartiles.
Statistical analysis
Ethnicity data were coded using a prioritized system, which
assigns people to a single, mutually exclusive category
based on an established (Ma¯ori, Pacific, non-Ma¯ori/non-
Pacific) hierarchy [18]. During the recruitment phase of the
study, ethnicity was based on that recorded on the NZCR or
on the Electoral Roll. Unweighted kappa statistics were
used to assess agreement between recorded and self-
reported ethnicity, as reported in the questionnaire. All
further analyses were then based on self-reported ethnicity,
as is standard practice in New Zealand health research.
Continuous variables were categorized using pre-defined
cut-offs or quantiles; Chi squared tests were used to com-
pare variable distributions across ethnic groups. Logistic
regression was used to estimate odds ratios (OR) and 95 %
confidence intervals (CI) adjusted for age group (four
categories) and menopausal status at diagnosis. Analyses
were reported stratified by ethnic group. Where effects
were found, exploratory analyses were conducted, strati-
fying results by menopausal status, and/or adjusting for
likely confounders. These results were presented in the text
rather than tables. In addition to visual inspection of the
ethnic-specific results, likelihood ratio tests were used as
formal tests of interaction between explanatory variables
and ethnicity. Due to the relatively small levels of missing
data, these were excluded from all models, with the
exception of nulliparous women in the analyses of age at
first live birth and ever having breast-fed, in which case
they were entered as a separate category.
Because of the low response rates in the control group (see
below) and the evidence of differential non-response by
deprivation quintile, we performed a sensitivity analysis to
investigate non-response bias, using post-stratification
weights. A weight was calculated for each stratum of eth-
nicity * deprivation, by dividing the expected deprivation
distribution of each ethnic group by the observed deprivation
distribution in the controls from our study. The expected
distributions were estimated from the 2002/2003 New Zea-
land Health Survey (unpublished data) and were 2, 3, 10, 20,
and 65 % for Ma¯ori and Pacific women in quintiles 1–5 of
the NZDep2006 categories and 23, 20, 20, 20, and 17 % for
non-Ma¯ori/non-Pacific women. Logistic regression models
were then weighted using the ‘‘svy: logistic’’ command in
Stata.
Ethical approval
The pilot study was approved by the Wellington Ethics
Committee, and the full study granted approval by the
Multi-Region Ethics Committee (WGT/03/12/126).
Results
Cases
A total of 2,984 women with breast cancer were identified
from the NZCR. Four women had a date of death on the same
day as the date of diagnosis, and 70 women had incomplete
files, so were not followed up. The remainder of CRDs, then
GPs, was contacted. A total of 2,356 women were invited to
take part, of whom 2,074 (88 %) responded, 1,869 (76 %)
agreed to take part, and 1,799 women completed a ques-
tionnaire. Further details are shown in Fig. 1. Most ques-
tionnaires were self-completed (n = 1,612, 89 %); the
remainder were completed over the telephone with an
interviewer (n = 155, 9 %) or at a face-to-face interview
(n = 32, 2 %). Based on the ethnicity from the NZCR, the
response rates in cases were 81 % in Ma¯ori, 46 % in Pacific,
and 78 % in non-Ma¯ori/non-Pacific women.
Details of recruitment of controls are shown in Fig. 2. A
total of 3,109 non-Ma¯ori/non-Pacific women were identi-
fied from the General Electoral Roll. Of these, 258 (8 %)
were returned to the study center as undelivered and 256
women who responded were not eligible (due to past breast
cancer, having already died or being too ill to participate).
Of the remaining 2,595 women, 1,473 (57 %) completed
the questionnaire. One thousand five hundred Ma¯ori
women were chosen from each of the General and Ma¯ori
Electoral Rolls. Of the 3,000, 623 (21 %) were returned to
the study center as undelivered. A further 148 women were
not eligible. Of the remaining 2,229, 850 (38 %) women
completed the questionnaire. We identified 1,200 women
from the General Electoral Roll with a name that sounded
of Pacific origin. Of these, 187 (16 %) were returned to the
study center as undelivered and a further 53 (4 %) were not
eligible. Of the remaining 960 women, 146 (15 %) were
interviewed. Given the poor response rates, additional
138 Cancer Causes Control (2013) 24:135–152
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methods of identifying controls were employed (see
above). This resulted in the recruitment of an additional 75
control women. In summary, the response rates among
controls were 38 % in Ma¯ori, 15 % in Pacific women, and
57 % in non-Ma¯ori/non-Pacific women, based on the eth-
nicity data in the routinely collected data sources.
In summary, the study comprised 1,799 cases (302 Ma¯ori,
70 Pacific, 1,427 non-Ma¯ori/non-Pacific) and 2,543 controls
(746 Ma¯ori, 194 Pacific, 1,603 non-Ma¯ori/non-Pacific),
based on self-identified ethnicity. There was good agreement
between the self-reported ethnicity and the data on ethnicity
from the NZCR (cases), kappa = 88 %, and Electoral Roll
(controls), kappa = 85 %. Among cases, the median time
(inter quartile range) from diagnosis to interview was
8.4 months in non-Ma¯ori/non-Pacific women (7.3–11.4),
12.1 months in Ma¯ori women (8.6–19.1), and 15.1 months
in Pacific women (11.7–19.2). The cases on the NZCR who
took part were compared to those who did not take part. Non-
Ma¯ori/non-Pacific and Pacific participants tended to be
slightly younger than non-participants (median age 57.9 vs.
60.4 years for non-Ma¯ori/non-Pacific; 49.1 vs. 51.2 for
Pacific cases), but no difference in median age between
Ma¯ori participants and non-participants was evident (53.9
vs. 53.7 years).
Table 1 shows the distribution of the main breast cancer
risk factors by ethnic group in cases and controls for
completeness; discussion of the distribution of these risk
factors between ethnic groups is restricted to the controls.
It is noticeable that the greatest burden of breast cancer in
the Pacific women in the study is in the under 50s, com-
pared to the 50–65 year age band in Ma¯ori and non-Ma¯ori/
non-Pacific women. Measures of socio-economic position
show higher levels of deprivation and lower levels of
education in Ma¯ori and Pacific women. The anthropometric
measures show strong evidence of differences between
ethnic groups. Ma¯ori and Pacific were taller, heavier and
had higher WHR and WHtR, coupled with a high preva-
lence of self-reported diabetes. Maternal breast cancer was
rarely reported by Pacific women.
Reproductive variables differed by ethnic group. Mean
age at menarche was lower in Ma¯ori (12.6 years) and non-
Ma¯ori/non-Pacific (12.9 years) than Pacific (13.4 years)
women. Greatest use of oral contraceptives and hormone
replacement therapy (HRT) was reported in non-Ma¯ori/
NZCR
2,984
DCO registration n=4 
File incomplete n=70 
CRDs contacted
n=2,910
No response n=136
GP details
provided
n=2,774
Not contacted, n=6
GP contacted
n=2,768
Did not reply, n=13
Did not agree, n=389
GPs agreed
n=2,366
(of which 756 needed a  reminder letter)
Not sent n=8
Questionnaires sent
n=2,358
(Maori 370, 136 Pacific, 1,852 nMnP) 
Questionnaire Refused to participate Did not respond
n=310942=Ncompleted
n=1,799
Fig. 1 Response rates in cases
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non-Pacific women, with lowest use in Pacific women.
Over 45 % of Pacific controls reported having had four or
more children, although it is noticeable that this pattern
was not seen in the cases, see below for further discussion.
Numbers of children were lower in Ma¯ori and non-Ma¯ori/
non-Pacific women; Ma¯ori women reported the greatest
proportion of births under age 20. Non-Ma¯ori/non-Pacific
women were more likely than other ethnic groups to have
ever breast-fed, but the total duration of breast feeding was
highest in Pacific women.
Ma¯ori women reported a very high prevalence of ever
having smoked. Over half of Pacific women reported never
drinking alcohol; the majority of Ma¯ori and non-Ma¯ori/
non-Pacific women were light drinkers. However, Ma¯ori
women who did drink alcohol reported that they drank a
higher number of drinks per occasion than other ethnic
groups. Ma¯ori women appeared to be less active and Pacific
women more active than non-Ma¯ori/non-Pacific women.
Over 98 % of cases were histologically confirmed, and
this proportion did not differ by ethnicity. Further details of
the cancers in the cases are given in Table 2. Among the
respondents, there was no significant difference in the stage
at presentation by ethnic group, but a high proportion of
Pacific women were recorded as having unknown stage.
The distribution by grade was similar between ethnic
groups, as was the proportion of cancers that were ER
positive. Ma¯ori women were more likely than the other
ethnic groups to have PR positive breast cancer; Ma¯ori and
Pacific women were more likely than non-Ma¯ori/non-
Pacific women to have HER2 positive breast cancer,
although the high degree of missing data for these latter
analyses means that the results should be interpreted with
caution. Among the women with a recorded ER, PR, and
HER2 status, 124 were negative for all three (‘‘triple
negative breast cancer’’). This was most common in non-
Ma¯ori/non-Pacific women (13 %), compared to 4 % in
Ma¯ori and 11 % in Pacific women, p = 0.002.
Associations between ‘‘known’’ risk factors and breast
cancer are shown in Table 3. In interpreting these data, it is
important to acknowledge the low statistical power among
Pacific women, and the large number of comparisons
made, thus increasing the likelihood of chance findings.
Furthermore, because of the evidence of differential non-
response by deprivation category, the results need to be
interpreted alongside those presented in Table 4, which
have been weighted to account for this possible selection
bias.
Although for some risk factors, the association with
breast cancer was similar between ethnic groups, for others,
there were interesting patterns of difference. For anthropo-
metric variables, Ma¯ori and non-Ma¯ori/non-Pacific women
had similar patterns of associations, with women reporting a
higher BMI, a higher WHR, or diabetes having a higher risk
of breast cancer than women without those risk factors. The
effect of weighting the controls for differential non-response
attenuated many of these relationships. Restricting the
results to women who were interviewed within 1 year of
diagnosis did not change the effect of BMI on postmeno-
pausal non-Ma¯ori/non-Pacific women, but attenuated the
effect in postmenopausal Ma¯ori women.
The overall patterns were less clear for Pacific women.
However, when Pacific women were restricted to those who
were postmenopausal at diagnosis/interview, there was a
suggestion of a positive association between BMI and
llor larotcelEllor larotcelEllor larotcelE
002,1= cificaP000,3= iroaM9013= PnMn
Not eligible Letters sent Not eligible Letters sent Not eligible Letters sent
069042922,2177595,2415
(of which 258 
return to sender)
(of which 623 
return to sender)
(of which 187 return 
to sender)
Refused Q complete Refused Q complete Refused Q complete
641418058973,1374,1221,1
Additional 
Pacific controls
DHB Pacific GPs of Pacific 
services = 50 cases = 25
Fig. 2 Response rates in controls. Note: The distributions by
ethnicity given here are based on ethnicity as recorded in the
electoral roll; numbers of participants according to self-identified
ethnicity are given in the text. One of the Ma¯ori women who
completed the questionnaire was subsequently excluded as she was
found to be a transgender female
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Table 1 Distribution of known risk factors, among breast cancer cases and controls in New Zealand, stratified by self-identified ethnicity
Cases Controls
nMnP
(n = 1,427)
Ma¯ori
(n = 302)
Pacific
(n = 70)
p value nMnP
(n = 1,603)
Ma¯ori
(n = 746)
Pacific
(n = 194)
p value
Age at interview
20–35 25 (1.8) 10 (3.3) 4 (5.7) 19 (1.2) 46 (6.2) 23 (11.9)
[35–50 377 (26.4) 97 (32.1) 37 (52.9) 334 (20.8) 289 (38.7) 73 (37.6)
[50–65 589 (41.3) 137 (45.4) 19 (27.1) 767 (47.9) 337 (45.2) 72 (37.1)
[65 436 (30.6) 58 (19.2) 10 (14.3) \0.001 483 (30.1) 74 (9.9) 23 (11.9) \0.001
Missing – – – – – 3 (1.5)
Interview method
Phone 106 (7.4) 47 (15.6) 2 (2.9) 207 (12.9) 65 (8.7) 9 (4.6)
Face 3 (0.2) 19 (6.3) 10 (14.3) 0 (0.3) 8 (1.1) 16 (8.3)
Post 1,318 (92.4) 236 (78.2) 58 (82.9) \0.001 1,396 (87.1) 673 (90.2) 169 (87.1) \0.001
Deprivation quintile
1–2 282 (19.8) 16 (5.3) 5 (7.1) 419 (26.1) 80 (10.7) 9 (4.6)
3–4 265 (18.6) 31 (10.3) 5 (7.1) 395 (24.6) 118 (15.8) 18 (9.3)
5–6 333 (23.3) 52 (17.2) 9 (12.9) 333 (20.8) 132 (17.7) 21 (10.8)
7–8 325 (22.8) 73 (24.2) 21 (30.0) 290 (18.1) 179 (24.0) 41 (21.1)
9–10 218 (15.3) 130 (43.1) 30 (42.9) \0.001 164 (10.2) 237 (31.8) 102 (52.6) \0.001
Missing 4 (0.3) – – 2 (0.1) – 3 (1.6)
Maternal breast cancer
Yes 167 (11.7) 28 (9.3) 3 (4.3) 101 (6.3) 37 (5.0) 4 (2.1)
No 1,237 (86.7) 262 (86.8) 66 (94.3) 0.019 1,476 (92.1) 677 (90.8) 176 (90.8) \0.001
Missing 23 (1.6) 12 (4.0) 1 (1.4) 26 (1.6) 32 (4.3) 14 (7.2)
Highest attained qualification
None 392 (27.5) 117 (38.7) 24 (34.3) 389 (24.3) 212 (28.4) 73 (37.6)
School qualification 287 (20.1) 35 (11.6) 12 (17.1) 271 (16.9) 122 (16.4) 27 (13.9)
Postschool qualification 745 (52.2) 150 (49.7) 33 (47.1) \0.001 942 (58.8) 409 (54.8) 93 (47.9) 0.001
Missing 3 (0.2) – 1 (1.4) 1 (0.1) 3 (0.4) 1 (0.5)
Height (cm)
\=160 402 (28.2) 94 (31.1) 21 (30.0) 441 (27.5) 209 (28.0) 55 (28.4)
160.1–165 429 (30.1) 80 (26.5) 12 (17.1) 485 (30.3) 207 (27.8) 38 (19.6)
165.1–170 326 (22.9) 60 (19.9) 16 (22.9) 371 (23.1) 154 (20.7) 43 (22.2)
[170 259 (18.2) 65 (21.5) 17 (24.3) 0.001 297 (18.5) 166 (22.3) 49 (25.3) \0.001
Missing 11 (0.8) 3 (1.0) 4 (5.7) 9 (0.6) 10 (1.3) 9 (4.6)
BMI (kg/m2)
\25 643 (45.1) 76 (25.2) 6 (8.6) 797 (49.7) 236 (31.6) 15 (7.7)
25–30 445 (31.2) 76 (25.2) 18 (25.7) 445 (27.8) 203 (27.2) 44 (22.7)
[30–40 282 (19.8) 109 (36.1) 22 (31.4) 292 (18.2) 212 (28.4) 83 (42.8)
[40 25 (1.8) 34 (11.3) 19 (27.1) \0.001 33 (2.1) 61 (8.2) 35 (18.0) \0.001
Missing 32 (2.2) 7 (2.3) 5 (7.1) 36 (2.3) 34 (4.6) 17 (8.8)
Waist–hip ratio (tertiles)
Min to 0.81 490 (34.3) 54 (17.9) 10 (14.3) 620 (38.7) 200 (26.8) 24 (12.4)
0.81–0.87 502 (35.2) 85 (28.2) 10 (14.3) 536 (33.4) 224 (30.0) 38 (19.6)
0.871 to max 394 (27.6) 145 (48.0) 44 (62.9) \0.001 393 (24.5) 296 (39.7) 119 (61.3) \0.001
Missing 41 (2.9) 18 (6.0) 6 (8.6) 54 (3.4) 26 (3.5) 13 (6.7)
Waist–height ratio (tertiles)
0.322–0.506 487 (34.1) 44 (14.6) 2 (2.9) 656 (40.9) 196 (26.3) 9 (4.6)
0.506–0.584 511 (35.8) 84 (27.8) 13 (18.6) 532 (33.2) 206 (27.6) 26 (13.4)
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Table 1 continued
Cases Controls
nMnP
(n = 1,427)
Ma¯ori
(n = 302)
Pacific
(n = 70)
p value nMnP
(n = 1,603)
Ma¯ori
(n = 746)
Pacific
(n = 194)
p value
0.584–1.280 379 (26.6) 154 (51.0) 47 (67.1) \0.001 353 (22.0) 311 (41.7) 139 (71.7) \0.001
Missing 50 (3.5) 20 (6.6) 8 (11.4) 62 (3.9) 33 (4.4) 20 (10.3)
Has had a diagnosis of diabetes
Yes 115 (8.1) 58 (19.2) 12 (17.1) 102 (6.4) 84 (11.3) 37 (19.1)
No 1,309 (91.7) 244 (80.8) 58 (82.9) \0.001 1,498 (93.4) 659 (88.3) 156 (80.4) \0.001
Missing 3 (0.2) – 3 (0.2) 3 (0.4) 1 (0.5)
Age at menarche
\12 233 (16.3) 71 (23.5) 16 (22.9) 261 (16.3) 162 (21.7) 25 (12.9)
12 338 (23.7) 73 (24.2) 9 (12.9) 354 (22.1) 203 (27.2) 41 (21.1)
13 444 (31.1 81 (26.8) 18 (25.7) 499 (31.1) 184 (24.7) 48 (24.7)
14? 387 (27.1) 70 (23.2) 26 (37.1) 0.017 472 (29.4) 189 (25.3) 75 (38.7) \0.001
Missing 25 (1.8) 7 (2.3) 1 (1.4) 17 (1.1) 8 (1.1) 5 (2.6)
Menopausal status at diagnosis/
interview
Premenopausal 413 (28.9) 95 (31.5) 38 (54.3) 392 (24.5) 332 (44.5) 95 (49.0)
Postmenopausal 1,014 (71.1) 207 (68.5) 32 (45.7) \0.001 1,211 (75.6) 414 (55.5) 99 (51.0) \0.001
Ever used oral contraceptive
Yes 1,058 (74.1) 202 (66.9) 33 (47.1) 1,282 (80.0) 592 (79.4) 80 (41.2)
No 367 (25.7) 98 (32.5) 36 (51.4) \0.001 318 (19.8) 147 (19.7) 112 (57.7) \0.001
Missing 2 (0.1) 2 (0.7) 1 (1.4) 3 (0.2) 7 (0.9) 2 (1.0)
Ever used HRT
Yes 342 (24.0) 40 (13.3) 2 (2.9) 397 (24.8) 91 (12.2) 4 (2.1)
No 1,068 (74.8) 260 (86.1) 68 (97.1) \0.001 1,191 (74.3) 646 (86.6) 189 (97.4) \0.001
Missing 17 (1.2) 2 (0.7) 0 15 (0.9) 9 (1.2) 1 (0.5)
Number of live births
0 185 (13.0) 34 (11.3) 15 (21.4) 154 (9.6) 79 (10.6) 30 (15.5)
1 142 (10.0) 43 (14.2) 13 (18.6) 135 (8.4) 85 (11.4) 16 (8.3)
2 465 (32.6) 61 (20.2) 14 (20.0) 548 (34.2) 182 (24.4) 31 (16.0)
3 364 (25.5) 55 (18.2) 16 (22.9) 448 (28.0) 196 (26.3) 25 (12.9)
4? 266 (18.6) 107 (35.4) 11 (15.7) \0.001 311 (19.4) 200 (26.8) 88 (45.4) \0.001
Missing 5 (0.4) 2 (0.7) 1 (1.4) 7 (0.4) 4 (0.5) 4 (2.1)
Ever breastfed
Yes 1,045 (73.2) 226 (74.8) 47 (67.1) 1,244 (77.6) 563 (75.5) 143 (73.7)
No 188 (13.2) 37 (12.3) 7 (10.0) 197 (12.3) 98 (13.1) 15 (7.7)
Nulliparous 185 (13.0) 34 (11.3) 15 (21.4) 154 (9.6) 79 (10.6) 30 (15.5)
Missing 9 (0.6) 5 (1.7) 1 (1.4) 0.17 8 (0.5) 6 (0.8) 6 (3.1) \0.001
Age at first live birth
Nulliparous 185 (13.0) 34 (11.3) 15 (21.4) 154 (9.6) 79 (10.6) 30 (15.5)
\20 159 (11.1) 97 (32.1) 11 (15.7) 181(11.3) 224 (30.0) 29 (15.0)
20–24 533 (37.4) 105 (34.8) 16 (22.9) 585 (36.5) 250 (33.5) 73 (37.6)
25–29 345 (24.2) 42 (13.9) 15 (21.4) 414 (25.8) 110 (14.8) 33 (17.0)
[=30 195 (13.7) 20 (6.6) 10 (14.3) \0.001 254 (15.9) 69 (9.3) 17 (8.8) \0.001
Missing 10 (0.7) 4 (1.3) 3 (4.3) 15 (0.9) 14 (1.9) 12 (6.2)
Total duration of breast feeding
(parous women)
Never 188 (15.1) 37 (13.8) 7 (12.7) 197 (13.6) 98 (14.7) 15 (9.2)
Up to 6 months 276 (22.2) 53 (19.8) 7 (12.7) 280 (19.3) 99 (14.8) 13 (7.9)
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breast cancer (OR per 5 kg/m2 1.19, 95 % CI 0.92–1.52),
which was not apparent for premenopausal breast cancer
(OR per 5 kg/m2 0.92, 95 % CI 0.69–1.22). When strati-
fying the Pacific women by menopausal status, the effect of
WHR tertile and diagnosis of diabetes were both stronger in
postmenopausal women, but none of the effects approached
statistical significance. Analyzing the WHtR as a dichoto-
mous variable, split at 0.5, gave similar patterns of associ-
ations as were seen for other measures of obesity; the OR
were 1.37 (95 % CI 1.17–1.61) in non-Ma¯ori/non-Pacific
women, 1.64 (95 % CI 1.12–2.42) in Ma¯ori women, and
1.47 (95 % CI 0.29–7.30) in Pacific women.
There was an unexpected protective effect of OC use on
breast cancer, evident in Ma¯ori and non-Ma¯ori/non-Pacific
women. This effect was unchanged following adjustment
for BMI, deprivation, and number of live births. Among
Ma¯ori women, duration of breast feeding explained part of
the protective effect of OC use (adjusted OR 0.73, 95 % CI
0.50–1.06). On stratification, the effect was apparent for
postmenopausal not premenopausal non-Ma¯ori/non-Pacific
women (adjusted OR 0.60 95 % CI 0.48–0.75). The effect
was weaker in the weighted analysis. No clear relationship
between ever use of HRT and breast cancer was detected,
although in non-Ma¯ori/non-Pacific women, the expected
increased risk was apparent, having weighted for differ-
ential non-response in the controls.
Evidence for an expected protective effect of later age at
menarche was weak in all ethnic groups. The protective
effect of having more children and ever having breast-fed
was particularly strong in Pacific women; age at first birth
was not strongly related to breast cancer risk in this study,
although there was a suggestion of a lower risk of breast
cancer among women who had had their first child over the
age of 30 years. Longer duration of breast feeding was
Table 1 continued
Cases Controls
nMnP
(n = 1,427)
Ma¯ori
(n = 302)
Pacific
(n = 70)
p value nMnP
(n = 1,603)
Ma¯ori
(n = 746)
Pacific
(n = 194)
p value
6–12 months 219 (17.6) 32 (11.9) 10 (18.2) 278 (19.2) 101 (15.1) 17 (10.4)
Over 12 months 550 (44.3) 141 (52.6) 30 (54.6) 0.058 686 (47.3) 363 (54.4) 113 (68.9) \0.001
Missing 9 (0.7) 5 (1.9) 1 (1.8) 8 (0.6) 6 (0.9) 6 (3.7)
Ever smoked
Yes 656 (46.0) 246 (81.5) 40 (57.1) 731 (45.6) 535 (71.7) 88 (45.4)
No 771 (54.0) 56 (18.5) 29 (41.4) \0.001 869 (54.2) 209 (28.0) 104 (53.6) \0.001
Missing – – 1 (1.4) 4 (0.2) 2 (0.3) 2 (1.0)
Frequency of alcohol consumption
Never 253 (17.7) 81 (26.8) 37 (52.9) 227 (14.2) 149 (20.0) 109 (56.2)
Monthly 339 (23.7) 100 (33.1) 16 (22.9) 343 (21.4) 241 (32.3) 50 (25.8)
2–4/month 240 (16.8) 64 (21.2) 9 (12.9) 312 (19.5) 141 (18.9) 18 (9.3)
2 or more per week 592 (41.5) 57 (18.9) 8 (11.4) \0.001 721 (45.0) 210 (28.2) 16 (8.2) \0.001
Missing 3 (0.2) 5 (0.7) 1 (0.5)
Usual amount of alcohol consumed
(drinks per occasion)
0 253 (17.7) 81 (26.8) 37 (52.9) 227 (14.2) 149 (20.0) 109 (56.2)
1–2 926 (64.9) 116 (38.4) 17 (26.3) 1,100 (68.6) 331 (44.4) 37 (19.1)
3–4 158 (11.1) 35 (11.6) 7 (10.0) 196 (12.2) 121 (16.2) 22 (11.3)
5? 51 (3.6) 66 (21.9) 9 (12.9) \0.001 50 (3.1) 133 (17.8) 25 (12.9) \0.001
Missing 39 (2.7) 4 (1.3) 30 (1.9) 12 (1.6) 1 (0.5)
Exercise frequency and intensity
(quartiles)
1 371 (26.0) 111 (36.8) 27 (38.6) 357 (22.3) 221 (29.6) 39 (20.1)
2 395 (27.7) 81 (26.8) 14 (20.0) 444 (27.7) 193 (25.9) 48 (24.7)
3 293 (20.5) 46 (15.2) 7 (10.0) 371 (23.1) 132 (17.7) 34 (17.5)
4 326 (22.9) 58 (19.2) 19 (27.1) 0.002 404 (25.2) 173 (23.2) 60 (30.9) \0.001
Missing 42 (2.9) 6 (2.0) 3 (4.3) 27 (1.7) 27 (3.6) 13 (6.7)
nMnP non-Ma¯ori/non-Pacific
* p values show differences between ethnic groups, omitting people with missing data
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associated with a lower risk of breast cancer in all ethnic
groups.
Although smoking is not traditionally thought of as a
‘‘known’’ breast cancer risk factor, it was included in our
analysis because of its importance for Ma¯ori public health.
There was clear evidence for an interaction with ethnicity,
with Ma¯ori women who had ever smoked having a 76 %
higher risk of breast cancer than those who had never
smoked. This was only partly explained by levels of
deprivation and education; further adjustment for these
factors only reduced the OR to 1.62 (95 % CI 1.14–2.30).
The effect in Ma¯ori women was attenuated when weighted
for differential non-response by deprivation level; in
Pacific women, the effect, although unstable, showed a
suggestion of a strengthening of effect. An estimation of
the population attributable fraction for smoking and breast
cancer in Ma¯ori based on this adjusted OR suggests that
approximately 31 % of the burden of breast cancer in
Ma¯ori women is attributable to smoking; however, this is
likely to be an overestimate due to residual confounding
and misclassification of deprivation and education.
Because of the relative rarity of frequent drinking, the
two upper categories of frequency of alcohol consumption
(‘‘2–4 drinks’’ and ‘‘4 or more drinks’’ per week) were
combined for analysis. There was weak evidence of an
inverse association between frequency of alcohol con-
sumption and breast cancer risk, although as shown in
Table 4, this disappeared in the weighted analysis. In the
unweighted analysis, the higher risk among women who
were never drinkers compared to those who drank one to
two drinks per occasion was eliminated in non-Ma¯ori/non-
Pacific and Pacific women when the data were restricted to
those who were interviewed within 1 year of diagnosis, but
persisted in Ma¯ori women. In women of all ethnicities,
exercise was associated with a lower risk of breast cancer.
The results were not materially changed in any ethnic
group when the data were restricted to those who were
interviewed within 1 year of diagnosis.
Table 2 Tumor characteristics
of breast cancer cases in New
Zealand
nMnP non-Ma¯ori/non-Pacific
* The p value shows the
difference between ethnic
groups, calculated after
excluding missing data
nMnP (n = 1,427) Ma¯ori (n = 302) Pacific (n = 70) p value*
Stage
Local 712 (49.9) 136 (45.0) 28 (40.0)
Regional 528 (37.0) 116 (38.4) 23 (32.9)
Distant 16 (1.1) 7 (2.3) 2 (2.9) 0.24
Unknown 171 (12.0) 43 (14.2) 17 (24.3)
Grade
Well differentiated 348 (24.4) 68 (22.5) 14 (20.0)
Moderately differentiated 587 (41.1) 134 (44.4) 31 (44.3)
Poorly differentiated 417 (29.2) 81 (26.8) 20 (28.6) 0.73
Unknown 75 (5.3) 19 (6.3) 4 (7.1)
ER positive
Yes 1,075 (75.3) 240 (79.5) 46 (65.7)
No 252 (17.7) 41 (13.6) 15 (21.4) 0.102
Unknown 100 (7.0) 21 (7.0) 9 (12.9)
PR positive
Yes 864 (60.6) 209 (69.2) 41 (58.6)
No 455 (31.9) 64 (21.2) 20 (28.6) 0.002
Unknown 108 (7.6) 29 (9.6) 9 (12.9)
HER2 positive
Yes 134 (9.4) 47 (15.6) 10 (14.3)
No 734 (51.4) 155 (51.3) 37 (52.9) 0.021
Unknown 559 (39.2) 100 (33.1) 23 (32.9)
Tumor size (mm)
\10 308 (21.6) 34 (11.3) 9 (12.9)
10–19 416 (29.2) 69 (22.9) 16 (22.9)
20–29 325 (22.8) 105 (34.8) 13 (18.6)
30? 255 (17.9) 58 (19.2) 19 (27.1) \0.001
Missing 123 (8.6) 36 (11.9) 13 (18.6)
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Table 3 Adjusted odds ratios (OR) and 95 % confidence intervals (CI) showing the association between known risk factors and breast cancer
risk in three ethnic groups in New Zealand
nMnP Ma¯ori Pacific
OR (95 % CI) OR (95 % CI) OR (95 % CI)
Deprivation quintile
1–2 1* 1* 1*
3–4 1.00 (0.80–1.24) 1.28 (0.65–2.51) 0.56 (0.12–2.51)
5–6 1.48 (1.19–1.84) 1.94 (1.03–3.65) 0.70 (0.18–2.78)
7–8 1.68 (1.35–2.10) 1.90 (1.03–3.51) 0.86 (0.25–3.00)
9–10 2.06 (1.59–2.66) 2.36 (1.31–4.26) 0.48 (0.14–1.60)
p (interaction)** 0.18
Maternal breast cancer
Yes 1.98 (1.52–2.56) 1.83 (1.07–3.12) 1.69 (0.35–8.15)
No 1* 1* 1*
p (interaction) 0.96
Highest attained qualification
None 1* 1* 1*
School qualification 0.98 (0.78–1.22) 0.69 (0.43–1.10) 1.35 (0.58–3.15)
Postschool qualification 0.72 (0.60–0.86) 0.84 (0.62–1.15) 1.16 (0.61–2.22)
p (interaction) 0.018
Height (cm)
\=160 1* 1* 1*
160.1–165 0.96 (0.80–1.16) 0.90 (0.63–1.30) 0.91 (0.39–2.14)
165.1–170 0.96 (0.78–1.17) 0.92 (0.61–1.37) 0.93 (0.42–2.06)
[170 0.92 (0.74–1.14) 1.00 (0.67–1.48) 0.77 (0.35–1.71)
p (interaction) 0.98
BMI (kg/m2)
\25 1* 1* 1*
25–30 1.29 (1.09–1.53) 1.10 (0.75–1.60) 1.22 (0.40–3.76)
[30–40 1.27 (1.04–1.55) 1.39 (0.97–1.99) 0.75 (0.25–2.20)
[40 0.98 (0.57–1.68) 1.58 (0.95–2.62) 1.71 (0.55–5.33)
p (interaction) 0.19
BMI (kg/m2), premenopausal women only
\25 1* 1* 1*
[=25 1.05 (0.79–1.40) 1.47 (0.88–2.46) 0.84 (0.21–3.28)
p (interaction) 0.37
BMI (kg/m2), postmenopausal women only
\25 1* 1* 1*
[=25 1.36 (1.15–1.62) 1.21 (0.82–1.80) 1.62 (0.32–8.62)
p (interaction) 0.94
Waist–hip ratio (tertiles)
1 1* 1* 1*
2 1.21 (1.02–1.44) 1.29 (0.86–1.92) 0.56 (0.20–1.59)
3 1.30 (1.08–1.57) 1.56 (1.08–2.26) 0.80 (0.35–1.85)
p (interaction) 0.28
Waist–height ratio (tertiles)
1 1* 1* 1*
2 1.37 (1.15–1.63) 1.58 (1.04–2.42) 2.40 (0.44–13.17)
3 1.54 (1.27–1.86) 1.82 (1.23–2.69) 1.57 (0.32–7.73)
p (interaction) 0.23
Has had a diagnosis of diabetes
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Table 3 continued
nMnP Ma¯ori Pacific
OR (95 % CI) OR (95 % CI) OR (95 % CI)
Yes 1.35 (1.02–1.79) 1.51 (1.03–2.22) 0.85 (0.41–1.78)
No 1* 1* 1*
p (interaction) 0.13
Age at menarche
\12 1.00 (0.80–1.24) 0.96 (0.65–1.43) 1.82 (0.76–4.32)
12 1.07 (0.88–1.30) 0.81 (0.55–1.19) 0.50 (0.20–1.27)
13 1* 1* 1*
14? 0.91 (0.76–1.10) 0.83 (0.57–1.23) 1.01 (0.49–2.11)
p (interaction) 0.23
Ever used oral contraceptive
Yes 0.67 (0.56–0.81) 0.65 (0.47–0.90) 1.19 (0.66–2.13)
No 1* 1* 1*
p (interaction) 0.014
Ever used HRT
Yes 1.08 (0.91–1.30) 0.98 (0.64–1.50) 1.89 (0.31–11.33)
No 1* 1* 1*
p (interaction) 0.70
Number of live births
0 1.17 (0.85–1.62) 0.99 (0.57–1.74) 0.67 (0.24–1.83)
1 1* 1* 1*
2 0.83 (0.64–1.09) 0.73 (0.45–1.19) 0.46 (0.17–1.28)
3 0.82 (0.62–1.08) 0.59 (0.36–0.95) 0.70 (0.26–1.92)
4? 0.86 (0.64–1.15) 0.92 (0.59–1.45) 0.13 (0.05–0.35)
p (interaction) \0.001
Age at first live birth
Nulliparous 1.25 (0.92–1.70) 1.19 (0.73–1.94) 1.52 (0.56–4.15)
\20 1* 1* 1*
20–24 1.00 (0.78–1.28) 0.93 (0.66–1.31) 0.51 (0.20–1.29)
25–29 0.86 (0.66–1.12) 0.99 (0.63–1.53) 1.12 (0.43–2.96)
[=30 0.76 (0.57–1.01) 0.76 (0.43–1.34) 1.25 (0.43–3.69)
p (interaction) 0.28
Ever breastfed
Yes 0.85 (0.68–1.06) 1.16 (0.76–1.78) 0.62 (0.23–1.71)
No 1* 1* 1*
Nulliparous 1.20 (0.89–1.62) 1.46 (0.82–2.60) 1.17 (0.37–3.72)
p (interaction) 0.71
Total duration of breast feeding (among parous women)
Never 0.98 (0.75–1.28) 0.67 (0.40–1.12) 1.09 (0.28–4.21)
Up to 6 months 1* 1* 1*
6–12 months 0.78 (0.61–1.00) 0.60 (0.35–1.01) 1.18 (0.34–4.09)
Over 12 months 0.77 (0.63–0.94) 0.73 (0.49–1.09) 0.55 (0.20–1.56)
p (interaction) 0.54
Ever smoked
Yes 1.01 (0.88–1.17) 1.76 (1.25–2.48) 1.60 (0.90–2.83)
No 1* 1* 1*
p (interaction) 0.006
Frequency of alcohol consumption
Never 1.13 (0.89–1.43) 1.08 (0.74–1.57) 1.01 (0.50–2.06)
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Discussion
The findings presented here report the first nationwide,
population-based, multi-ethnic study of breast cancer in
New Zealand. The results show differences in exposure
prevalence between ethnicities and differing patterns of
risk factors for breast cancer between the three main ethnic
groups.
Many of the findings in this study are in agreement with
those previously reported, but we have also highlighted
some important differences. Some of the lack of associa-
tions in Pacific women in particular may be due to insuf-
ficient statistical power, since this was the smallest ethnic
group studied. More generally, our study is affected by the
limitations of case–control studies, particularly those
involving interviews, principally the potential for selection
and recall bias. Non-differential misclassification is also
likely to have affected the results. To minimize selection
bias, we attempted to maximize the response rate.
Although this was good among cases (over 75 %), the
response rates were poor among controls, ranging from
15 % in Pacific women to 59 % in non-Ma¯ori/non-Pacific
women. The Pacific controls are therefore unlikely to be
representative of the population of Pacific women in New
Zealand. However, the paucity of research in this popula-
tion group means that our work is the first documentation
of breast cancer risk factors, measured on an individual
level, in Pacific women.
If non-response is non-differential across determinants
of breast cancer risk, the effect of the low response rates
will simply be to reduce the numbers of women available
for analysis, that is, the ‘‘non-responders’’ will be ‘‘miss-
ing’’ completely at random. However, this is unlikely to be
the case. Although we did not have much information on
the non-responders, we used the national distribution of the
deprivation measure to investigate this further. Impor-
tantly, we found that our response rates were lower in
women living in the most deprived areas, which may have
biased the results based on markers of socio-economic
position, as well as those which are socially patterned. The
post-stratification weighting that we used was intended to
address this. The greatest effect that the weighting had was
on the effect of deprivation itself. For other factors, the
weighting tended to dilute the observed effects. We
therefore remain cautious in our interpretation of the results
presented, given the potential for selection bias in our
study.
Unlike any other ethnic group, the greatest burden of
breast cancer in the Pacific women in the study is in the
under 50s. This is consistent with data from Hawaii, where
the ‘‘Asian/Pacific Islander’’ group is reported to have a
lower age at diagnosis than white women [19, 20]. A recent
Table 3 continued
nMnP Ma¯ori Pacific
OR (95 % CI) OR (95 % CI) OR (95 % CI)
B Monthly 1* 1* 1*
2–4 drinks/month 0.75 (0.60–0.95) 1.21 (0.82–1.78) 1.39 (0.51–3.82)
2 or more drinks/wk 0.81 (0.67–0.98) 0.70 (0.47–1.02) 1.47 (0.52–4.16)
p (interaction) 0.082
Usual amount of alcohol consumed (drinks per occasion)
0 1.33 (1.08–1.63) 1.24 (0.87–1.78) 0.76 (0.37–1.56)
1–2 1* 1* 1*
3–4 0.90 (0.72–1.14) 0.86 (0.56–1.34) 0.72 (0.25–2.06)
5? 1.12 (0.74–1.67) 1.55 (1.07–2.26) 0.83 (0.31–2.22)
p (interaction) 0.53
Exercise frequency and intensity (quartiles)
1 1* 1* 1*
2 0.88 (0.72–1.08) 0.89 (0.63–1.28) 0.44 (0.20–0.97)
3 0.77 (0.62–0.95) 0.80 (0.53–1.22) 0.32 (0.12–0.86)
4 0.80 (0.65–1.00) 0.77 (0.52–1.13) 0.43 (0.21–0.91)
p (interaction) 0.53
OR are adjusted for age, menopausal status at diagnosis and interview method (postal, telephone or face-to-face interviews)
nMnP non-Ma¯ori/non-Pacific
* Reference category
** Test of interaction of differences in OR between ethnic groups
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Table 4 Weighted, adjusted Odds Ratios (OR) and 95 % confidence
intervals (CI) showing the association between known risk factors and
breast cancer risk in three ethnic groups in New Zealand, weighted
using post-stratification weights to account for differential non-
response bias by deprivation quintile
nMnP Ma¯ori Pacific
OR (95 % CI) OR (95 % CI) OR (95 % CI)
Deprivation quintile
1–2 1* 1* 1*
3–4 1.02 (0.86–1.21) 1.88 (1.02–3.48) 1.51 (0.37–6.19)
5–6 1.07 (0.91–1.26) 1.08 (0.61–1.92) 0.68 (0.17–2.74)
7–8 0.92 (0.78–1.08) 0.94 (0.54–1.64) 1.65 (0.49–5.49)
9–10 0.42 (0.35–0.51) 0.64 (0.38–1.10) 1.68 (0.51–5.57)
Highest attained qualification
None 1* 1* 1*
School qualification 1.13 (0.88–1.45) 0.82 (0.50–1.34) 1.06 (0.44–2.60)
Postschool qualification 0.89 (0.73–1.08) 0.97 (0.70–1.36) 0.97 (0.47–2.01)
Height (cm)
\=160 1* 1* 1*
160.1–165 1.05 (0.85–1.30) 1.02 (0.70–1.52) 0.83 (0.32–2.10)
165.1–170 1.09 (0.87–1.36) 1.04 (0.68–1.65) 1.19 (0.52–2.74)
[170 1.01 (0.79–1.30) 1.04 (0.67–1.59) 0.99 (0.40–2.18)
BMI (kg/m2), premenopausal women only
\25 1* 1* 1*
[=25 1.12 (0.82–1.55) 1.45 (0.83–2.51) 0.95 (0.23–3.92)
BMI (kg/m2), postmenopausal women only
\25 1* 1* 1*
[=25 1.29 (1.06–1.56) 0.99 (0.64–1.52) 2.23 (0.39–12.67)
Waist–hip ratio (tertiles)
1 1* 1* 1*
2 1.18 (0.97–1.43) 1.23 (0.79–1.92) 0.51 (0.15–1.75)
3 1.21 (0.97–1.49) 1.27 (0.83–1.93) 0.94 (0.34–2.58)
Waist–height ratio (tertiles)
1 1* 1* 1*
2 1.26 (1.03–1.54) 1.41 (0.89–2.24) 1.52 (0.24–9.68)
3 1.38 (1.11–1.71) 1.47 (0.97–2.23) 1.37 (0.25–7.58)
Has had a diagnosis of diabetes
Yes 1.25 (0.91–1.72) 1.43 (0.96–2.14) 0.91 (0.39–2.11)
No 1* 1* 1*
Age at menarche
\12 0.90 (0.70–1.15) 0.98 (0.65–1.50) 1.71 (0.66–4.39)
12 0.96 (0.77–1.21) 0.82 (0.54–1.25) 0.44 (0.16–1.26)
13 1* 1* 1*
14? 0.81 (0.66–1.00) 0.81 (0.53–1.22) 1.05 (0.47–2.31)
Ever used oral contraceptive
Yes 0.78 (0.64–0.96) 0.80 (0.57–1.12) 1.06 (0.56–2.02)
No 1* 1* 1*
Ever used HRT
Yes 1.18 (0.97–1.44) 1.09 (0.69–1.71) 0.91 (0.11–7.21)
No 1* 1* 1*
Number of live births
0 1.10 (0.76–1.57) 1.07 (0.59–1.94) 0.74 (0.23–2.34)
1 1* 1* 1*
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report from New Zealand demonstrated higher rates of
breast cancer in Pacific women in New Zealand aged under
45 compared to European New Zealanders, and lower rates
of Pacific women aged over 65 years [7]. This suggests that
at least part of the burden of breast cancer that we report is
due to a true difference in rates, rather than solely due to
the young ages of the Pacific population in New Zealand. It
may be explained by cohort effects and patterns of
migration, with the older Pacific women in New Zealand
experiencing similar rates to the historically low rate of
breast cancer in some Pacific Islands [9], although reasons
for the higher rates in younger Pacific women remains
unexplained.
Breast cancer has repeatedly been demonstrated to be a
disease more common in affluent people [21–23]. Although
in our main results, we found a higher risk in more
Table 4 continued
nMnP Ma¯ori Pacific
OR (95 % CI) OR (95 % CI) OR (95 % CI)
2 0.84 (0.63–1.13) 0.77 (0.46–1.29) 0.65 (0.21–2.03)
3 0.78 (0.58–1.06) 0.54 (0.32–0.90) 0.80 (0.25–2.53)
4? 0.74 (0.54–1.03) 0.84 (0.52–1.36) 0.18 (0.06–0.53)
Age at first live birth
Nulliparous 1.48 (1.04–2.12) 1.45 (0.86–2.45) 1.10 (0.35–3.44)
\20 1* 1* 1*
20–24 1.17 (0.89–1.56) 1.03 (0.71–1.49) 0.40 (0.14–1.13)
25–29 1.10 (0.82–1.48) 1.09 (0.68–1.74) 0.94 (0.31–2.83)
[=30 1.12 (0.81–1.54) 1.02 (0.54–1.93) 1.18 (0.36–3.82)
Ever breastfed
Yes 0.97 (0.76–1.25) 1.16 (0.74–1.82) 0.71 (0.24–2.14)
No 1* 1* 1*
Nulliparous 1.31 (0.92–1.85) 1.63 (0.87–3.05) 1.10 (0.29–4.15)
Total duration of breast feeding (among parous women)
Never 0.88 (0.63–1.24) 0.67 (0.37–1.21) 1.39 (0.27–7.11)
Up to 6 months 1* 1* 1*
6–12 months 0.75 (0.55–1.03) 0.62 (0.34–1.12) 1.54 (0.27–8.86)
Over 12 months 0.83 (0.64–1.08) 0.69 (0.44–1.09) 0.75 (0.19–2.99)
Ever smoked
Yes 0.96 (0.82–1.12) 1.40 (0.98–2.01) 1.73 (0.94–3.17)
No 1* 1* 1*
Frequency of alcohol consumption
Never 1.10 (0.84–1.44) 1.00 (0.66–1.49) 1.05 (0.47–2.35)
B Monthly 1* 1* 1*
2–4 drinks/month 0.91 (0.70–1.16) 1.30 (0.87–1.95) 1.18 (0.41–3.37)
2 or more drinks/wk 1.00 (0.81–1.23) 0.87 (0.58–1.29) 1.29 (0.41–4.02)
Usual amount of alcohol consumed (drinks per occasion)
0 1.09 (0.86–1.38) 0.94 (0.63–1.39) 0.81 (0.36–1.45)
1–2 1* 1* 1*
3–4 0.85 (0.66–1.10) 0.68 (0.43–1.10) 0.65 (0.21–1.99)
5? 0.88 (0.56–1.38) 1.23 (0.83–1.81) 0.85 (0.29–2.49)
Exercise frequency and intensity (quartiles)
1 1* 1* 1*
2 1.01 (0.81–1.27) 0.99 (0.68–1.46) 0.39 (0.16–0.97)
3 0.94 (0.74–1.20) 0.86 (0.55–1.36) 0.29 (0.09–0.88)
4 0.94 (0.75–1.21) 0.84 (0.56–1.26) 0.35 (0.14–0.84)
OR are adjusted for age, menopausal status at diagnosis and interview method (postal, telephone, or face-to-face interviews)
* Reference category
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deprived women, this was reversed in non-Ma¯ori/non-
Pacific and Ma¯ori women in the weighted analysis. This
latter analysis is concordant with the high rate of breast
cancer reported in women in New Zealand in the highest
income tertile [7]. Data from UK have found that the
association between deprivation and breast cancer differs
by age [24], with only small differences across deprivation
groups in young women, and the largest differences in
women in the screening age group. A possible explanation
is the higher proportion of familial cancers in younger
women [24]. Furthermore, studies suggest that deprivation
may be associated with a higher risk of some breast cancer
sub-types, notably ones of poorer prognosis [23]. In addi-
tion, differential associations between deprivation and
breast cancer between younger and older women may be
partially due to differences in detection due to differences
in screening attendance, which is lower in Ma¯ori and
Pacific women [25]. Of interest in our weighted analysis is
the discordance in effect that we report between two
measures of socio-economic position (area-level depriva-
tion and education). This suggests that the observed results
could be due to reverse causality, caused by sick people
moving to poorer areas, rather than being attributable to a
lifetime of exposure to adverse risks.
The very strong association that we demonstrated
between number of children and breast cancer risk in Pacific
women is of interest. It is possible that this is a true effect,
detectable more readily in Pacific women because of the
higher number of children borne by women in the most
extreme category (four or more children). The mean num-
ber of children in this highest group was 5.1 in Pacific
women, 4.9 in Ma¯ori, and 4.5 in non-Ma¯ori/non-Pacific
women. It is also possible that this effect is stronger in
Pacific women than in other women, because of differences
in confounding structures between ethnic groups. For
example, there was an apparent inverse association between
number of children and BMI in Pacific women, as opposed
to a strong positive relationship between number of children
and BMI in Ma¯ori, which was weaker but still evident in
non-Ma¯ori/non-Pacific women.
A recent analysis of the Women’s Health Initiative
observational study found a positive association between
smoking and postmenopausal breast cancer risk [26].
Among Ma¯ori women in this study, we have identified a
substantial risk associated with ever having smoked, which
translated to a population attributable fraction of 31 %.
This is likely to be an overestimate due to residual con-
founding. Nevertheless, it may in part be real and may be
more evident among women who smoke heavily for many
years. It is also important to consider the possibility of
there being a critical or sensitive period, such as smoking
prior to first pregnancy [2, 27] or during pregnancy [28].
Ma¯ori have the highest rates of smoking among women
worldwide, approaching 50 % [29], and start smoking
heavily at a younger age than other women. A stronger
effect of smoking in Ma¯ori women compared to other
ethnic groups, coupled with high rates of obesity in Ma¯ori,
is not consistent with a recently reported interaction
between smoking and obesity and breast cancer [30], with
higher risks in smokers only evident in non-obese women.
Careful further analysis of this is warranted, to disentangle
possible confounding and effect modification and to iden-
tify the duration and level of smoking that is driving the
high risk in Ma¯ori women.
We did not find an association between height and breast
cancer, despite clear evidence for an association from
systematic reviews [31]. It is implausible that international
evidence does not apply to the total New Zealand popu-
lation. In our systematic review [31], it was clear that the
association between height and breast cancer is less robust
in case–control studies than in cohort studies. This suggests
that if height is measured relatively late in life, as in this
study, when women have already begun to experience age-
related height loss, this is not related to breast cancer as
strongly as is maximally attained height. This would sug-
gest that height loss may be an indicator of breast cancer
risk, for example if height loss is a marker of estrogen
levels which affect bone loss.
The suggestion of differential effects of BMI across
ethnic groups could be due to chance, as we have per-
formed multiple significance tests in this initial report,
although we have restricted these analyses to ‘‘established’’
risk factors. In non-Ma¯ori/non-Pacific women, the detri-
mental effect is clear in overweight women, but is not
stronger in obese women. In Ma¯ori women, on the other
hand, the excess risk appears to be restricted to obese
women. Small numbers hamper the ability to look at this
clearly in Pacific women. The stronger effect of WHtR
than BMI is similar to that detected in cardiovascular dis-
ease [32], but this is one of the first explorations of this
measure in relation to breast cancer. We recommend that
future studies investigate the use of this measure; since
BMI does not capture the percentage of body fat equally
between ethnic groups [33], an easily interpreted measure
of central obesity is useful and less prone to measurement
error than WHR.
The expected association between alcohol and breast
cancer risk was not seen in this study; further investigation
of this is ongoing. We found some evidence of a detri-
mental effect of binge drinking, particularly in Ma¯ori
women. This is consistent with recently reported data from
the Nurses’ Health Study [3]. The rate of binge drinking in
New Zealand is high and is disproportionate between eth-
nic groups; the age-adjusted prevalence is reported as 39 %
in Ma¯ori; 31 % in Pacific, and 22 % in European women
[34]. Given the excess burden of the alcohol-related harm
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borne by Ma¯ori, this is an important area for future
research.
The lack of an association between HRT and breast
cancer is contrary to that reported in prospective studies
and clinical trials. A likely explanation is the crude mea-
sure of ‘‘ever use of HRT’’ that was used in this study; the
risk is higher for combined estrogen/progesterone HRT
compared to estrogen-only HRT [35] and also differs by
cancer subtype [36]. The protective effect of OC use in
Ma¯ori and non-Ma¯ori/non-Pacific women differs from that
previously reported and did not appear to be explained by
any of the variables available to us for which we adjusted.
The observation that the effect was attenuated following
adjustment for differential non-response indicates that the
results may well be affected by residual confounding. New
Zealand women have a very high use of Depo-Provera, and
its use is more common among Ma¯ori than women of other
ethnic groups [37]. One possibility is that the protective
effect of OC use which we found could reflect a harmful
effect of other hormonal contraceptive methods. This, plus
the lack of an effect of OC use in Pacific women is further
evidence that the effect in Ma¯ori and non-Ma¯ori/non-
Pacific women is unlikely to be causal.
In summary, we have documented some expected, and
other unexpected, associations between environmental
factors and breast cancer risk in New Zealand; we have
also found ethnic differences in exposure to risk factors and
the associations of these factors with breast cancer. Despite
methodological and statistical attempts to reduce the
impact of selection bias on the results, we urge that these
are interpreted with caution. This is the first such nation-
wide study to be conducted in New Zealand, with adequate
numbers of women in different ethnic groups. Future
studies need to ensure the use of appropriate methodologies
to allow recruitment of participants from all ethnic groups.
Most promising avenues for future research are likely to be
investigations into the detrimental effects of smoking and
binge drinking in relation to breast cancer risk. Reducing
the burden of breast cancer in New Zealand is likely to
require different approaches for different ethnic groups.
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